Effect of supplementation in treatment of pregnancy complications

Phase 3

• Conditions: Pre-eclampsia.; Sequelae of complication of pregnancy, childbirth and the puerperium

• Registration Number: IRCT201102135444N3
• Lead Sponsor: Vice chancellor for research, Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 June 2021

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Primigravida pregnant women
Aged 18–40 years old
At risk for pre-eclampsia
Lived approximately 20 km or less from the clinic and hospital

Exclusion Criteria

Hypertension
Renal diseases
Gestational diabetes mellitus (GDM)
Abnormal foetal anomaly scan

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pre-eclampsia rate. Timepoint: After delivery. Method of measurement: Medical record.;Low birth weight (LBW) (<2500 g). Timepoint: After delivery. Method of measurement: Scale.;Newborn's birth size. Timepoint: After delivery. Method of measurement: Scale and tape.;Preterm delivery (<37 weeks). Timepoint: After delivery. Method of measurement: Medical record.

Secondary Outcome Measures

Name	Time	Method
Insulin. Timepoint: Baseline and End-of-trial. Method of measurement: Eliza.;Nitric oxide. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;High-sensitivity C-reactive protein. Timepoint: Baseline and End-of-trial. Method of measurement: Eliza.;Total antioxidant capacity. Timepoint: Baseline and End-of-trial. Method of measurement: Spectrophotometry.;Fasting plasma glucose. Timepoint: Baseline and End-of-trial. Method of measurement: Enzymatic.;Triglyceride. Timepoint: Baseline and End-of-trial. Method of measurement: Enzymatic.;Cholesterol. Timepoint: Baseline and End-of-trial. Method of measurement: Enzymatic.;HDL-cholesterol. Timepoint: Baseline and End-of-trial. Method of measurement: Enzymatic.;Blood pressures. Timepoint: Baseline and End-of-trial. Method of measurement: Manometer.